Target intelligence / Profile preview

C2orf49 divergent transcript (C2orf49-DT)

Target
C2orf49-DT
Molecular classification
Other (non-coding RNA, divergent transcript)
01

Overview

C2orf49 divergent transcript (C2orf49-DT) refers to a non-coding RNA transcript expressed in a divergent orientation from the genomic locus of the protein-coding gene C2orf49 (chromosome 2 open reading frame 49). Divergent transcripts are typically long non-coding RNAs (lncRNAs) that are generated by divergent transcription, a process in which promoters produce RNAs in both directions. While C2orf49 itself is a protein-coding gene with predicted roles in tRNA splicing and may participate in RNA processing complexes, the "divergent transcript" form (C2orf49-DT) does not encode a protein and lacks characterized biological function, molecular interactions, or disease associations. There is no evidence to date that C2orf49-DT acts as a therapeutic target, and it is not recognized as an established receptor, enzyme, transporter, or other therapeutic class. The entry "C2orf49 divergent transcript" is correctly labeled as a noncoding transcript but is not a validated therapeutic target. Most so-named "divergent transcripts" related to open reading frames (e.g., C2orfxx-DT) are catalogued in gene databases for annotation purposes, not for any known functional or druggable role. If your intent is to target C2orf49-DT therapeutically or include it in structured target lists, it should be excluded as there is insufficient evidence for biological or pharmacological relevance as a target. If you are seeking information on the protein-coding gene, use "Chromosome 2 open reading frame 49 (C2orf49)" instead, as this has defined molecular features and potential links to pathway biology.

Other names
C2orf49-DTC2orf49 divergent transcript
02

Biological functions

Other (no clearly defined function)
03

Disease associations

Other (no established role in disease)

Beyond the preview

Go deeper on C2orf49 divergent transcript (C2orf49-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on C2orf49 divergent transcript (C2orf49-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call